DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Fetzima (Levomilnacipran Hydrochloride) - Published Studies


Fetzima Related Published Studies

Well-designed clinical trials related to Fetzima (Levomilnacipran)

Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trials. [2014]

Well-designed clinical trials possibly related to Fetzima (Levomilnacipran)

Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. [2014]

Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial. [2013]

The dubious effect of milnacipran for the treatment of burning mouth syndrome. [2011]

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011]

Milnacipran: beyond a role of antidepressant. [2009]

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. [2008]

Resolution of sexual dysfunction during acute treatment of major depression with milnacipran. [2008]

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. [2007]

A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder. [2007]

Efficacy of milnacipran in patients with fibromyalgia. [2005]

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. [2004]

Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. [2003]

Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects. [2003]

A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder. [1997]

Other possibly related research studies

Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. [2013]

Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial. [2013]

Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). [2012]

Desvenlafaxine in the treatment of major depressive disorder. [2011]

Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: a double-blind randomized placebo-controlled trial. [2011]

[Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment]. [Article in Japanese] [2010]

Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. [2010]

Pharmacological treatment of fibromyalgia syndrome: new developments. [2010]

Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study. [2010]

Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine. [2009]

Milnacipran versus other antidepressive agents for depression. [2009]

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. [2009]

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. [2009]

Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia. [2008]

Effects of milnacipran and paroxetine on overactive bladder due to neurologic diseases: a urodynamic assessment. [2008]

The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran. [2008]

Are SNRIs more effective than SSRIs? A review of the current state of the controversy. [2008]

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis. [2008]

[Pharmacological treatment of fibromyalgia]. [Article in Italian] [2007]

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. [2007]

Fibromyalgia treatment update. [2007]

Characterization and consequences of pain variability in individuals with fibromyalgia. [2005]

Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression. [2005]

Controlled comparison of two different doses of milnacipran in major depressive outpatients. [2004]

Which bioequivalence study for a racemic drug? Application to milnacipran. [1998]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017